NCT07052084View on ClinicalTrials.gov

Systematic Adjunction of Vasopressine in Septic Shock

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2026

Primary Completion Date

February 29, 2028

Study Completion Date

February 29, 2028

Conditions
Septic Shock
Interventions
DRUG

Vasopressin administration

Low dose of vasopressin (0.02ui /min), maximum 5 days

DRUG

Sodium chloride administration

NaCl 0.9 %, maximum 5 days

Trial Locations (1)

13005

Assistance Publique - Hôpitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER